GlassScriptPhysician profile
Mark Balceniuk
NPI 1255725636
$3,771.22
in general payments reported to CMS, 2019-2025
11 companies · $993 in 2025
The $993 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2021: $18.29 · 2023: $1,477 · 2024: $1,008 · 2025: $993.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,976 · Education: $349 · Travel and Lodging: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,976.40 |
| Education | $348.80 |
| Travel and Lodging | $152.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,010.19 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $712.58 | 2023-2025 | Enroute Transcarotid Neuroprotection System, Eluvia, General - Vascular Intervention |
| W. L. Gore & Associates, INC. | $625.78 | 2023-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Vbx Balloon Expandable Endo |
| Medtronic, INC. | $613.95 | 2023-2025 | Endurant Iis, Heli-Fx Endoanchor System, Closurefast |
| Endologix LLC | $539.99 | 2023-2025 | Afx2 Bifurcated Endograft System, Torus Stent Graft System, Endocross Device |
| Lemaitre Vascular, INC. | $112.95 | 2023-2025 | Artegraft Vascular Graft, Hydro Lemaitre Valvulotome, Restoreflow |
| Shockwave Medical, INC | $87.80 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Solventum Corporation | $21.66 | 2025 | V.A.C.Ulta, Prevena |
| Inari Medical, INC. | $18.29 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.11 | 2024 | Jardiance |
| Smith+Nephew, INC. | $13.92 | 2024 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Balceniuk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.